
FDA draft guidance highlights the growing importance of long-read sequencing for genome editing safety assessment
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxQWFJPVGxSMTNkcHhoUkRCZHFsRWhKY25GRUJkb0IyazZaSmhONG5XcUUyOTF5ZnhCam5kV0hUTzBJOW1ibk9HelQ3WXJFY0lYUXRtYk14VktYcXhKTEZfdFdMUlU5dUtNaHQ2VzU0Qi1lYWpwTVc2QWZkbjJBNHhxbDI2SXpQUlhPNVpyQ0xGcnc2S0FPUndfeC1iY0RtTk1RVk1QdGxrNUlzMWM5bXVHSHhTYVc2Y1RXSzFmU2R2SkZCcnZNOWhOVVdwdHhlZ3NhNnBDSml5bw?oc=5" target="_blank">FDA draft guidance highlights the growing importance of long-read sequencing for genome editing safety assessment</a>&nbsp;&nbsp;<font color="#6f6f6f">PacBio</font>

